Autopsy report · NCT03942172

Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses

“The study protocol needed to be modified”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months after it had already started.
• Suspended: paused, and may or may not restart.
• 50 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

SpotOn Therapeutics Ltd.

Sponsor type

Industry

Conditions

Parkinson Disease

Interventions

SpotOn balance glasses

Participants

50 (planned, not actual)

Sites

1

Countries

Israel

Trials that died the same way

• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (86% match in meaning)
• OsseoFit™ Prospective Data Collection
  “Planning new study protocol” (84% match in meaning)
• Study of Stored Tumor Samples in Young Patients With Brain Tumors
  “New Protocol that replaces the current study” (84% match in meaning)
• Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria
  “Substantially redesigning study protocol and opening a new study in the future.” (83% match in meaning)
• Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
  “study will be started under a new modified protocol” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.